首页>
外国专利>
USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNF-a THERAPY
USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNF-a THERAPY
展开▼
机译：拉喹莫德治疗一线抗TNF-a失败的克罗恩病患者的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
#$%^&*AU2017200472A120170209.pdf#####Abstract This application provides for a method of treating a human patient afflicted with anti-TNFa refractory Crohn's disease, of treating a human patient afflicted with nonfibrostenotic Crohn's disease, and of treating a human patient whose Crohn's disease had not been surgically treated, the method comprising periodically administering to the patient an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the patient. This application also provides for a method of inducing or maintaining clinical remission in a human patient afflicted with Crohn's disease comprising periodically administering to the patient an amount of laquinimod effective to induce or maintain clinical remission in the patient, which amount of laquinimod is less than 0.5 mg/day.
展开▼
